Telix Pharmaceuticals TLPPF
NASDAQ TLPPF
$10.99 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLPPF) Prepaid Assets (2023 - 2026)

Telix Pharmaceuticals' (TLPPF) quarterly Prepaid Assets came in at $26.7 million in Q2 2026, up 65.91% quarter-over-quarter from $16.1 million in Q4 2025.

Analysis

Telix Pharmaceuticals (TLPPF) Prepaid Assets (2023 - 2026) Analysis & Trends

Telix Pharmaceuticals (TLPPF) has reported Prepaid Assets for 4 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets changed N/A year-over-year to $26.7 million in Q2 2026; TTM through Jun 2026 was $26.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $16.1 million, up 17.8% from the prior year.
  • Prepaid Assets was $26.7 million for Q2 2026 at Telix Pharmaceuticals, up from $16.1 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $26.7 million in Q2 2026 and troughed at $12.7 million in Q4 2023.
  • A 4-year average of $17.3 million and a median of $14.9 million in 2025 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets increased 8.64% in 2024 and rose 16.52% in 2025, its largest moves.
  • Over 4 years, Prepaid Assets stood at $12.7 million in 2023, then increased by 8.64% to $13.8 million in 2024, then climbed by 16.52% to $16.1 million in 2025, then surged by 65.91% to $26.7 million in 2026.
  • The last three Prepaid Assets figures came in at $26.7 million (Q2 2026), $16.1 million (Q4 2025), and $13.8 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.49 Bn 198.50 Bn 7.24 Bn
2 Gilead Sciences 180.93 Bn 177.75 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.39 Bn 124.53 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.17 Bn 74.18 Bn 3.93 Bn
5 Argenx Se 61.05 Bn 55.87 Bn 1.37 Bn
6 Moderna 55.19 Bn 50.05 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.99 Bn 30.68 Bn 992.69 Mn
8 Biogen 31.30 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 29.91 Bn 29.91 Bn 1.16 Mn
10 Telix Pharmaceuticals 3.72 Bn 3.43 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.69 Mn
Dec 31, 2025 16.09 Mn
Dec 31, 2024 13.81 Mn
Dec 31, 2023 12.71 Mn